Intech Biopharm Ltd Working Capital to Net Assets Ratio
Intech Biopharm Ltd working capital to net assets ratio. Intech Biopharm Ltd (6461) has a Working Capital to Net Assets ratio of -1.6% as of March 2026. Working capital of NT$-15.60 Million (current assets of NT$395.60 Million minus current liabilities of NT$411.20 Million) is measured against net assets of NT$991.64 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Intech Biopharm Ltd's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Intech Biopharm Ltd (2017–2025)
Working capital to net assets ratio of Intech Biopharm Ltd from 2017 to 2025. This chart shows how Intech Biopharm Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at -1.6%, reflecting working capital of NT$-15.60 Million against net assets of NT$991.64 Million TWD. See 6461 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Intech Biopharm Ltd Working Capital to Net Assets Ratio by Year (2017–2025)
Intech Biopharm Ltd working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Intech Biopharm Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 6461 total asset value.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 14.5% | NT$159.81 Million | NT$1.10 Billion | NT$403.13 Million | NT$243.32 Million | ▲ +11.6 pp |
| 2024 | 2.9% | NT$23.68 Million | NT$814.28 Million | NT$410.32 Million | NT$386.64 Million | ▼ -7.9 pp |
| 2023 | 10.8% | NT$126.30 Million | NT$1.17 Billion | NT$695.02 Million | NT$568.73 Million | ▲ +0.6 pp |
| 2022 | 10.2% | NT$105.24 Million | NT$1.03 Billion | NT$479.06 Million | NT$373.82 Million | ▲ +0.2 pp |
| 2021 | 10.0% | NT$133.11 Million | NT$1.34 Billion | NT$456.33 Million | NT$323.22 Million | ▼ -9.3 pp |
| 2020 | 19.2% | NT$255.25 Million | NT$1.33 Billion | NT$409.77 Million | NT$154.52 Million | ▲ +9.4 pp |
| 2019 | 9.8% | NT$153.23 Million | NT$1.57 Billion | NT$360.22 Million | NT$206.99 Million | ▲ +11.2 pp |
| 2018 | -1.4% | NT$-20.70 Million | NT$1.49 Billion | NT$231.12 Million | NT$251.81 Million | ▼ -0.3 pp |
| 2017 | -1.1% | NT$-14.78 Million | NT$1.36 Billion | NT$163.75 Million | NT$178.53 Million | — |